Latest Continuous Disclosure News

Ioneer Ltd has issued 252.5 million new shares under a recent placement, complying fully with the Corporations Act while opting out of additional investor disclosures.

Monash IVF Group has affirmed its compliance with ASX continuous disclosure rules following a clinical incident involving an embryo transfer error at its Clayton laboratory. The company clarified the materiality and timing of its disclosures in response to ASX inquiries.

Western Gold Resources has confirmed a binding toll milling agreement with Wiluna Mining Corporation, explaining recent unusual trading activity in its shares.

Patronus Resources has clarified that its recent share price jump stems from a third-party research report rather than undisclosed company news, following an ASX inquiry. The company also confirmed the recent release of exploration results from its Western Australian gold projects.

Cobre Limited has announced a fully underwritten loyalty options offer to raise approximately $1.18 million, offering eligible shareholders one new option for every three shares held at $0.008 each. The new options carry an exercise price of $0.066 and expire in November 2028.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.

AGL Energy has confirmed it is reviewing its 20% stake in Tilt Renewables following recent media speculation, though no sale discussions are underway. The outcome remains uncertain as the company conducts preliminary assessments.

Alma Metals Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with ASX rules.

Bastion Minerals has confirmed it is finalising a JORC Mineral Resource Estimate for its ICE Copper Gold Project, explaining recent sharp price and volume movements in its shares. The company plans to announce the estimate by June 10, 2025.

Invion Limited has addressed ASX queries over the timing and content of its cleansing notice, confirming encouraging early results from its Phase I/II non-melanoma skin cancer trial using Photosoft™ technology.

Northern Minerals Limited has responded to ASX inquiries about recent unusual trading activity, confirming no undisclosed information but highlighting ongoing project developments and market factors influencing its share price.

InVert Graphite Limited has been reinstated to ASX quotation following its compliance with key listing rules, ending its trading suspension.